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Background: Hereditary syndromes frequently need the cooperation of different specialties to increase diagnostic
competence. Multiple cutaneous and uterine leiomyomatosis syndrome is a rare autosomal dominant disorder
caused by the mutations of the fumarate hydratase gene, demonstrated in 80 to 100 percent of affected individuals.
This can be linked to an increased risk of renal cancer in both sexes. The skin involvement is described to highlight the
diagnostic role of the cutaneous counterpart in identifying this rare syndrome.
Case presentation: A 37-year-old woman suffering from several uterine fibroids presented multiple, painful,
papulo-nodules on her left subscapular side, both forearms and legs. The patient underwent surgery on six
lesions: five were leiomyomas, whilst one was a dermatofibroma. Genetic sequencing did not evidence known
fumarate hydratase gene mutations. Dermoscopy showed a brown delicate pigmented network and included
leiomyomas among the non-melanocytic benign skin tumours featuring a dermatofibroma-like pattern. Abdominal
computerized-tomography scan did not reveal renal cancer, but brain magnetic resonance imaging showed one
asymptomatic cerebral cavernoma. The patient benefited from the surgical removal of the five larger cutaneous lesions
and from gabapentin, which relieved her pain.
Conclusions: This observation highlights the usefulness of dermoscopy in the diagnosis of cutaneous leiomyomas
disclosing multiple cutaneous and uterine leiomyomatosis syndrome. Dermoscopy should be performed for
non-melanocytic multiple lesions mimicking leiomyomas in a large number of patients, to establish a strict classification
and identify false negative cases or evaluate them as dermatofibromas. In this case, the dermatologist recognized the
risk of renal cancer and cerebral cavernomas.
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Multiple cutaneous and uterine leiomyomatosis (MCUL),
previously known as Reed's syndrome, is an autosomal
dominant disease with incomplete penetrance character-
ized by the onset of uterine leiomyomas or fibroids and
skin leiomyomas in both sexes [1,2]. The coexistence
of cutaneous and uterine leiomyomas may cluster pap-
illary type2 renal-cell carcinoma or renal collecting duct
cancer, codifying a recent variant appointed as hereditary* Correspondence: lauradiluvio@yahoo.it
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unless otherwise stated.leiomyomatosis and renal cell cancer (HLRCC) [3]. Even
though different gene mutations, missense, nonsense or
whole gene deletions have been described in MCUL
syndrome, a definite association between site or type
of mutation and the risk of papillary renal-cell carcinoma
has not been found yet [4]. Cutaneous leiomyomas -
accounting for 75% of all extra-uterine leiomyomas - are
uncommon benign smooth muscle tumours deriving ei-
ther from the erector pili muscle of the pilosebaceous
unit (piloleiomyomas), the cutaneous vascular smooth
muscle fibers (angioleiomyomas) or from the dartos
muscle (genital leiomyomas) [5]. Piloleiomyomas are
the most common form and show firm, skin-colored orLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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to 2.0 cm in diameter, distributed in single, clustered,
segmental or disseminated patterns. Linear or segmental
leiomyomas may present a dermatomal-like distribution
[6]. Common locations include trunk, extensor surface of
the extremities and face, more often in adulthood then in
childhood. Neoplasms can be asymptomatic or quite
debilitating and actually painful mainly in response
to pressure or cold temperature [7]. Clinical differential
diagnoses include several skin lesions, such as dermatofi-
broma, eccrine spiradenoma, neurofibroma, angiolipoma,
neurilemmoma, glomus tumour, keloid, hamartomas and
blue rubber bleb nevus syndrome when painful, or dermal
nevus, trichoepithelioma, lipoma, cylindroma or poroma
among the asymptomatic tumours [8]. The skin involve-
ment of a case of MCUL syndrome is reported to support
the diagnostic role of the cutaneous counterpart in identi-
fying this rare syndrome. We present and discuss a case of
multiple cutaneous lesions and the usefulness of dermo-
scopy for a better understanding of skin leiomyomas in the
wide spectrum of non-melanocitic lesions.
Case presentation
A 37-year-old woman complained of an 18-year history
of progressive onset of multiple, firm, smooth, soft,
pink-to-brown papules and nodules on her left sub
scapular region and both forearms, ranging from 1 to
2 cm in diameters. Some lesions were arranged in
dermatomal-like clustered nodules and plaques on her
left upper back (Figure 1). The lesions could become
symptomatic after mechanical injury, pressure, cold ther-
mal stimuli or emotional stress. Moreover, we observedFigure 1 Clinical picture of the patient. Pink-to-brown papules and nodbrownish nodular lesions on her leg similar to a dermato-
fibroma, displaying the most common pattern (Figure 2).
Past medical history included early menarche, disme-
norreas, menometrorrhagia, anaemia and uterine fibro-
matosis with myomectomy in 2000. Her family history
did not reveal similar skin lesions in kindred nor any
history of uterine diseases, hysterectomies or renal can-
cers. A total of 50 cutaneous lesions were counted in our
patient; the patient had already removed a large cuta-
neous leiomyoma in 2003. Five larger nodules were
surgically removed to solve the pain and distress caused
by their size. Histology confirmed the diagnosis of cuta-
neous piloleiomyomas. Our main finding was a dermal
proliferation of irregular interlacing bundles of benign
smooth muscle cells with minimal atypia and scarce
proliferative activity (Figure 3A). Antibodies against α-
smooth muscle actin (Figure 3B), desmin and myosin
positively stained the neoplastic growth. Moreover, the
histological examination of the leg lesion confirmed the
presence of dermatofibroma.
Genetic analysis was performed using RNA extracted
from a leiomyoma biopsy. Complete coding region se-
quencing of all 10 exons of Fumarate Hydratase gene
(Gb #NM_000143) was evaluated using direct sequen-
cing of RT-PCR amplified FH transcript. The sequence
did not reveal nucleotide changes in coding region, due
to the presence of amino acid substitutions. This does
not exclude the possible presence of complex genomic
mutations located inside introns, which could lead to ab-
normal transcripts. The level of enzymatic FH analysis
should be investigated to further characterise the pa-
tients for FH activity depletion. Complete routine bloodules on her left sub scapular region and both forearms.
Figure 2 Dermoscopic feature of dermatofibroma of the patient. Central white scar like patch with delicate pigment network in
dermatofibroma of the leg.
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computerized-tomography (CT) scan displayed uterine
fibroids and normal appearing kidneys. Brain magnetic res-
onance imaging (MRI) showed one asymptomatic cerebral
cavernoma (data not shown).
Dermoscopy was performed using Dermlite ® with non–
contact polarized light on each cutaneous leiomyoma.
A delicate dermatofibroma-like pigment network - due
to thin lines of pinkish-light brown colour and regular
meshes - was present in all lesions (Figure 4). The network
was regularly distributed and gradually faded into the sur-
rounding skin. No vascular structures were observed. In
some lesions, a white cloud-like area without scar features
was observed (Figure 5). As expected, reflectance confocal
microscopy (RCM) did not show any remarkable find-
ings due to the deep dermal location of the proliferation.Figure 3 Morphological and immunohistochemical myocitic aspect of
poorly circumscripted lesion from interlacing bundles of benign smooth m
α-smooth muscle actin of leiomyoma cells. Original magnification, ×200; B,Leiomyoma-related discomfort significantly improved with
gabapentin - started from 75 mg/die and then increased up
to 225 mg/die for 1 month - with marked reduction of
the pain.
Conclusions
Hereditary syndromes frequently need the cooperation of
different specialties, and MCUL/HLRCC disorder is a rele-
vant example of this occurrence. The skin is often part of
hereditary syndromes. Alongside the clinical and histo-
logical approach, we investigated if, in vivo, non-invasive,
methods of investigations, dermoscopy or RCM, could in-
crease our diagnostic skills. Cutaneous leiomyomas are
dermal proliferations of benign smooth muscle fibres; in
these cases, the diagnostic role of superficial investigations
is regarded as possibly uncertain. A new interesting findinga skin leiomyoma. (A) Hematoxilyn-Eosin stained section reveals a
uscle cells; (B) Immunohistochemistry confirms the positivity for
Diaminobenzidine as chromogen.
Figure 4 Dermoscopic feature of leiomyoma. Delicate dermatofibroma-like pigment network with thin lines of pinkish-light brown colour and
regular meshes in all lesions.
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among the non-melanocytic benign skin tumours featuring
a dermatofibroma-like appearance. In all leiomyomas
we observed a delicate pigment network with thin lines
of pinkish-light brown colour and regular meshes, regu-
larly distributed and gradually faded into the surrounding
skin. The larger lesions could present vascular struc-
tures, although they were not representative for most
piloleiomyomas (Figure 4). In some piloleiomyomas weFigure 5 Different dermoscopic feature of leiomyoma. White cloud-likedocumented masses of “white like-cloud” areas without
translucent streaks, typical of the dermoscopic central
scar-like patch in dermatofibroma (Figure 5). However,
as also recently described by Paschoal, we did not see hy-
perpigmented circular and/or elongated structures within
the central hypopigmented area [9].
The pigmented network pattern seems reasonably re-
lated to a reactive epidermal basal hyperpigmentation, as
observed in the histologically confirmed lesions, due toarea without scar features.
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myoma. RCM, as expected, did not give consistent results
because of the deep dermal location of the proliferation.
Surprisingly, our patient presented also a dermatofi-
broma, characterized by a white scar like patch sur-
rounded by a delicate pigment network (Figure 2); this
gave us the opportunity to better distinguish the dermo-
scopic findings and to establish specific criteria for dif-
ferential diagnosis [10]. Before a pigmented network
pattern of clinically non-melanocytic lesions, the dermo-
scopic differential diagnosis should consider seborrheic
keratosis, solar lentigo, dermatofibroma, and supernumer-
ary accessory nipple [11].
Although screening guidelines for MCUL/HLRCC syn-
drome have not been defined yet, Smit listed practical
criteria to ensure an appropriate diagnostic approach
[12]. Suspected MCUL should always motivate a histo-
logical diagnosis of at least one cutaneous lesion. DNA
analysis to test FH mutations should be recommended
for all patients with familiar or severe cutaneous or uter-
ine leiomyomatosis to eventually detect an occult renal
malignancy, with genetic counselling in positive cases.
Furthermore, since some mutations could not be de-
tected via standard sequencing analysis, an accurate en-
zymatic test should be developed to verify FH activity in
patient cells. An accurate follow-up should include an-
nual cutaneous and gynaecological examinations for
the risk of leiomyosarcoma, together with annual renal
ultrasound investigations. Furthermore, since cerebral
angiomatosis has been also described in MCUL patients,
dermatologists and gynaecologists should consider the
relative risk of cerebral haemorrhages through brain
MRI [13]. If in females coincident uterine fibroids with
often multiple and segmental cutaneous leiomyomas
suggest the diagnosis of MCUL syndrome, in males, the
most common solitary appearance of the cutaneous le-
sions and the obvious absence of the gynaecological
counterpart, make the diagnostic suspicion difficult, thus
amplify the risk of a late diagnosis of a possible renal in-
volvement. Besides surgery for large or painful lesions,
nifedipine, phenoxybenzamine, nitroglycerine, doxazosin,
gabapentin, topical lidocaine or capsaicin, carbon dioxide
laser ablation or botulinum toxin injections, have been
variously tested to improve the symptoms [14–16].
Our observation highlights the role of dermoscopy in
the diagnosis of cutaneous leiomyomas disclosing this
hereditary syndrome for the risk of renal cancer and
cerebral cavernomas. Dermoscopy should be performed
on non-melanocytic multiple lesions mimicking leiomyo-
mas in a large number of patients, to establish a strict
classification, in order to identify false negative cases
or evaluate them as dermatofibromas. The role of the
dermatologist is crucial in the final diagnosis of this rare
syndrome in a patient with multi organ involvement.Therefore, dermoscopy can be considered as an adjuvant
tool that gives some extra information before histology.
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